Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 8/2021

01-08-2021 | Crohn's Disease | Correspondence

Growth Delay in Inflammatory Bowel Diseases: The Importance of Surgery

Authors: Rogério Serafim Parra, José Joaquim Ribeiro da Rocha, Omar Féres

Published in: Digestive Diseases and Sciences | Issue 8/2021

Login to get access

Excerpt

Growth retardation can be found in up to 40% of patients with inflammatory bowel disease (IBD) [1]. Wong et al. [2] recently published in Digestive Diseases and Sciences a review discussing growth delay with height and weight impairment as a common feature of pediatric inflammatory bowel disease (PIBD). The study is very relevant and added important information about the significance, aetiology, and clinical management of PIBD. However, the authors did not discuss in depth the surgery as part of the treatment of PIBD when there is growth and development delay. …
Literature
1.
2.
3.
4.
5.
6.
Turner D, Ruemmele FM, Orlanski-Meyer E et al. Management of paediatric ulcerative colitis, Part 2: acute severe colitis-an evidence-based consensus guideline from the European Crohn's and Colitis organization and the European society of paediatric gastroenterology, hepatology and nutrition. J Pediatr Gastroenterol Nutr. 2018;67:292–310.CrossRefPubMed
7.
M'Koma AE. Inflammatory bowel disease: an expanding global health problem. Clin Med Insights Gastroenterol. 2013;6:33–47.CrossRef
8.
Metadata
Title
Growth Delay in Inflammatory Bowel Diseases: The Importance of Surgery
Authors
Rogério Serafim Parra
José Joaquim Ribeiro da Rocha
Omar Féres
Publication date
01-08-2021
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 8/2021
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-07091-2

Other articles of this Issue 8/2021

Digestive Diseases and Sciences 8/2021 Go to the issue

PROFILES AND PERSPECTIVES

DDS Profile: Deborah D. Proctor, MD

DDS – SIRC Author Profile

Author Spotlight: Maria Chiara Cianci

Original Article

Increased HLA-G Expression in Tissue-Infiltrating Cells in Inflammatory Bowel Diseases

Original Article

Characteristics and Outcomes of Patients Undergoing Endoscopy During the COVID-19 Pandemic: A Multicenter Study from New York City

Original Article

Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events

EDITORIAL

Enhanced Screening for Hepatitis D in the USA: Overcoming the Delta Blues
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits